- Global Pharma News & Resources

Pharmaceutical Granulators Market To Find Better Growth with US$ 5,299.5 Million By 2027 | CAGR: 5.6%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Pharmaceutical Granulators Market, by Product Type (Single Pot Granulators, High Sheer Granulators, Fluid Bed Granulators, Rapid Mixer Granulators, Oscillating Granulators, and Others), by Granulation Mechanism (Dry Granulators, Wet Granulators, and Mixed Granulators), by End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing Organizations, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 3,435.8 million in 2019 and is expected to exhibit a CAGR of 5.6% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

Get FREE Sample PDF Including COVID-19 Impact Analysis:

Granulators are rotor machines, which converts fine powder to granules through a series of physical processes. Granulation is a process, where small particles are accumulated together to form a large permanent mass. Moreover, granulators has major application in the pharmaceutical industry for manufacturing tablets, capsules, and other forms of medicines.

Moreover, rapidly growing pharmaceutical industry is expected to drive growth of the global pharmaceutical granulators market over the forecast period. The insufficient production capability of manufacturing sites can hamper demand for high volume pharmaceuticals. For instance, according to the National Center for Biotechnology Information 2017, high sheer wet granulation and fluid bed drying were identified to be critical unit operations that impact drug dosage formulation. Pharmaceutical companies are establishing new manufacturing facilities and expanding existing ones in terms of upgrading the manufacturing equipment and procedures. For instance, in November 2017, Fresenius Kabi invested over US$ 100 Million in expansion of its manufacturing facility at Wilson, U.S. Similarly, Piramal Pharma Solutions, an India-based drug manufacturer invested US$ 55 Million for expansion of API manufacturing units in North America and India, in October 2017.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@

Furthermore, market players are focusing on enhancing performance of the granulators. Major players are focused on developing novel and innovative solutions to strengthen their market position. For instance, in June 2015, L B Bohle Maschinen launched BRC 25, a small dry granulator with low maintenance for easy handling, continuous production, and small footprint. Additionally, in 2015, Bosch Packaging Technology launched a new granulation unit called GranuLean that facilitates a complete and quick granulation procedure of pharmaceutical ingredients in a compact size unit. In addition, market players are also focusing on participating in various trade fairs, conferences, and others to showcase their products, and expand their consumer base. For instance, in March 2017, Buhler Group showcased its latest innovative AHPE900 granulator at VIV ASIA 2017, as one of its marketing strategy.

Browse 34 Market Data Tables and 33 figures spread through 187 pages and in-depth TOC on ‘Global Pharmaceutical Granulators Market, Forecast to 2027’

To know the latest trends and insights related to global pharmaceutical granulators market press release, click the link below:

Moreover, several initiatives are taken by government and non-governmental organizations to scale up pharmaceutical manufacturing process that is leading to number of new player entries in the pharmaceutical production sector, which is expected to drive growth of the market. The entry of local players in the pharmaceutical industry is accompanied by funding and subsidies provided by government to these players in terms of facility & equipment set-up which helps the companies to start small and mid-sized manufacturing units. Granulators are an integral part of these units, as these are the primary stage unit processors in oral dosage formulations. For instance, according to the provisions of 2015 – 16 Union Budget of India, a national center to develop bulk drugs and facilitate their research was set up in Hyderabad, India.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Key Takeaways of the Global Pharmaceutical Granulators Market:

  • The global pharmaceutical granulators market is expected to exhibit a CAGR of 5.6% over the forecast period (2019-2027), attributed to automation of drug development procedures involving installation of upgraded automatic instruments, which is expected to fuel demand for pharmaceutical granulators. For instance, in July 2017, Boehringer Ingelheim invested US$ 217 million for upgrading and expanding its manufacturing facility in Fremont, California.
  • Among product type, high shear mixer granulators segment is expected to hold dominant position in the global pharmaceutical granulators market over the forecast period, attributed to increasing demand for high-shear granulators in pharmaceutical R&D.
  • Key players operating in the global pharmaceutical granulators market include L.B. Bohle, Alexanderwerk, GEA Group Aktiengesellschaft, Frewitt S.A., LINXIS Group, Spraying Systems Co., Syntegon Technology GmbH, Romaco Group, Gebrüder Lödige Maschinenbau GmbH, and Glatt GmbH

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Sep-2020